Imvax Company

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Technology: Whole-Cell Antigens
Industry: Whole-Cell Antigens
Headquarters: Philadelphia, Pennsylvania, United States
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: Late Stage Venture
Investors Number: 6
Total Funding: 166700000
Estimated Revenue: Less than $1M
Last Funding Date: 2020-07-16
Last Funding Type: Series C

Visit Website
contact@imvax.com
Register and Claim Ownership